NCT04080284
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma treatment 2 recruiting NCT01198184
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00025467
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT00416455
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer No drug interventions diagnostic 1 / 2 completed NCT00072176
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer treatment 2 completed NCT05256225
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma treatment 2 / 3 recruiting NCT02142803
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors treatment 1 active_not_recruiting NCT02065687
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer treatment 2 / 3 unknown_status NCT01225887
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT01440998
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer treatment 1 completed NCT03422198
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer No drug interventions treatment 3 recruiting NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT00006011
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer treatment 3 completed NCT02112552
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer treatment 2 terminated NCT00575952
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer treatment 1 completed NCT04494113
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy treatment 0 recruiting NCT04585958
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer treatment 1 suspended NCT01210222
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer treatment 2 completed NCT00005830
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer treatment 1 completed NCT02874430
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer treatment 2 active_not_recruiting NCT01010126
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer treatment 2 completed NCT00478426
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer treatment 2 completed NCT01935973
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 1 completed NCT00005840
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer treatment 1 completed NCT02501954
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol treatment 3 completed NCT02020707
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers treatment 1 completed NCT01344837
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer No drug interventions Not Available Not Available completed NCT01737619
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer diagnostic Not Available active_not_recruiting NCT01935934
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer treatment 2 active_not_recruiting NCT02728258
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer treatment 2 completed NCT00942357
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer treatment 3 unknown_status NCT03836157
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer treatment 2 withdrawn NCT03660826
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone treatment 2 active_not_recruiting NCT00977574
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer treatment 2 active_not_recruiting NCT01132820
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT01642082
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT01307631
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer No drug interventions treatment 2 completed NCT00888173
Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT01005329
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer treatment 2 completed NCT00807768
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer treatment 3 unknown_status NCT02315469
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery No drug interventions Not Available Not Available completed NCT03914612
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer treatment 3 active_not_recruiting NCT05049538
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in High-Risk Endometrial Cancers No drug interventions Not Available Not Available recruiting